Bloomage Biotechnology: Heavyweight Approval as Exclusive Agent of Korea's No.1 Sculptra, Medical Aesthetics Pipeline Expands

English summary

### Bloomage Biotechnology: Heavyweight Approval as Exclusive Agent of Korea's No.1 Sculptra, Medical Aesthetics Pipeline Expands Time: 2026-07-30 20:24:17 Content: Consumption is starting to rise from lows. Consumption that beauty-loving women all need, and medical aesthetics is quietly strengthening: Lance rose 41%, Imeik rose 24%. Bloomage Biotechnology is expected to start from lows with heavyweight stimulus: [Tianfeng Commercial & Social] Bloomage Biotechnology: The agency for Korea's Sculptra JUVELOOK officially approved, medical aesthetics pipeline expands again. Korea's Sculptra JUVELOOK officially obtained NMPA approval (National Medical Device Import Registration No.: 20263130274), exclusively distributed by Bloomage Biotechnology, adding another heavyweight new product to its ECM aging intervention layout. Perfecting the regenerative matrix and opening growth space. JUVELOOK (composition: 85% PDLLA + 15% HA), as the No.1 Sculptra in South Korea by market share, has won the Korean Consumer Award and AMWC Best Injectable Product multiple times. Global cumulative sales exceed 3 million bottles, exported to more than 65 countries, filling the gap in high-end Sculptra products and forming strong synergy with existing hyaluronic acid products. …